Paul Mischel, Yeva Margaryan
CancerWorld/LinkedIn

Paul Mischel’s Work on ecDNA is Changing How We Understand Treatment Resistance – CancerWorld

CancerWorld shared a post on LinkedIn:

“Maybe ‘terminal’ doesn’t mean what it meant anymore.

Prof. Paul Mischel has spent his life turning loss into purpose, and purpose into discoveries that could redefine cancer care.

His work on extra-chromosomal DNA (ecDNA) is changing how we understand treatment resistance and giving new hope to patients once thought out of options.

But his legacy isn’t just in discoveries, it’s in every mind he’s mentored, and every life those minds will go on to save.

Read the full profile article by Yeva Margaryan, MD, MPH.”

You can also read AI Isn’t Replacing Radiologists: It’s Empowering Them – CancerWorld

Paul Mischel, Yeva Margaryan